Eléments de l'association

	J. Graeme Hodgson	1
	Protein Kinase Inhibitors (therapeutic use)	15
	J. Graeme Hodgson *Sauf* Protein Kinase Inhibitors (therapeutic use)"	0
	Protein Kinase Inhibitors (therapeutic use) *Sauf* J. Graeme Hodgson"	14
	J. Graeme Hodgson Et Protein Kinase Inhibitors (therapeutic use)	1
	J. Graeme Hodgson Ou Protein Kinase Inhibitors (therapeutic use)	15
	*Corpus*	4588

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000974	Michael W. Deininger [États-Unis] ; J. Graeme Hodgson [États-Unis] ; Neil P. Shah [États-Unis] ; Jorge E. Cortes [États-Unis] ; Dong-Wook Kim [Corée du Sud] ; Franck E. Nicolini [France] ; Moshe Talpaz [États-Unis] ; Michele Baccarani [Italie] ; Martin C. Müller [Allemagne] ; Jin Li [États-Unis] ; Wendy T. Parker [Australie] ; Stephanie Lustgarten [États-Unis] ; Tim Clackson [États-Unis] ; Frank G. Haluska [États-Unis] ; Francois Guilhot [France] ; Hagop M. Kantarjian [États-Unis] ; Simona Soverini [Italie] ; Andreas Hochhaus [Allemagne] ; Timothy P. Hughes [Australie] ; Victor M. Rivera [États-Unis] ; Susan Branford [Australie]	Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024